PMID: 9532341Apr 9, 1998Paper

Treatment of Graves' disease: the American way

Baillière's Clinical Endocrinology and Metabolism
E G Levy

Abstract

The treatment of patients with Graves' disease involves a physician making a clinical decision between one of the three modalities available for treatment, administering the treatment and following the patients. There appears to be a difference in treatment bias for treating the 'average' patient with Graves' disease, with American physicians preferring radioactive iodine while their European and Japanese cohorts prefer long-term anti-thyroid drugs. There are no facts to support this bias. The treating physician usually makes the decision based on his or her preference. In addition, American physicians are under pressure to prescribe the most cost-effective therapy, leading to an even stronger bias towards radioactive iodine.

References

Jan 1, 1991·Thyroid : Official Journal of the American Thyroid Association·L WartofskyM Izumi
Jun 1, 1990·The Journal of Clinical Endocrinology and Metabolism·B SolomonL Wartofsky
Aug 29, 1991·The New England Journal of Medicine·G Medeiros-Neto
Oct 1, 1987·Annals of Internal Medicine·B L SolomonL Wartofsky
Jun 1, 1987·The Journal of Clinical Endocrinology and Metabolism·B M LippeS A Kaplan
Oct 1, 1987·The Journal of Clinical Endocrinology and Metabolism·K OkamuraM Fujishima
Dec 1, 1986·Annals of Internal Medicine·G D Graham, K D Burman
Jun 1, 1984·Clinical Endocrinology·N MomotaniT Mimura
Jan 1, 1983·Annals of Internal Medicine·D S CooperE C Ridgway
Jun 16, 1994·The New England Journal of Medicine·J A Franklyn
Aug 1, 1996·Postgraduate Medical Journal·E B JudeP M Dodson
Mar 1, 1997·Clinical Obstetrics and Gynecology·D A Fisher
Apr 1, 1997·Thyroid : Official Journal of the American Thyroid Association·L Wartofsky
Apr 1, 1997·Thyroid : Official Journal of the American Thyroid Association·J H Lazarus, S Clarke
May 1, 1995·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·D S Ross
May 1, 1995·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·C Levetan, L Wartofsky

❮ Previous
Next ❯

Citations

Jul 18, 2008·Journal of Clinical Immunology·Wei ZhaoYong-Neng Jiang
Jun 14, 2001·Lancet·T J McKenna
Jan 22, 2002·Journal of the American College of Surgeons·Kazuo ShimizuShigeo Tanaka
Nov 9, 2000·The New England Journal of Medicine·A P Weetman
Apr 6, 2001·Thyroid : Official Journal of the American Thyroid Association·P Werga-KjellmanG Wallin
Jul 10, 2004·Thyroid : Official Journal of the American Thyroid Association·Kiminori SuginoKunihiko Ito
Jul 15, 2006·Thyroid : Official Journal of the American Thyroid Association·N N PatelM P J Vanderpump
Dec 7, 2000·Australian and New Zealand Journal of Medicine·J P Walsh
Nov 15, 2008·Endocrine Journal·Wei ZhaoDian Ping Song
Jul 9, 2011·Head & Neck·Murat KaramanArzu Tatlıpınar
Jun 18, 2016·Journal of Thyroid Research·D M SmithM A Thaha
Jan 16, 2007·Arquivos brasileiros de endocrinologia e metabologia·Marcus V L de SouzaRonir Raggio Luiz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.